These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 35534635
1. Nonexposed antiresorptive agent-related osteomyelitis of the jaw: a single-center cohort study. Watanabe T, Yoshida T, Akizuki S, Yamanaka S, Nakao K, Fukuhara S, Asai K, Uozumi R, Bessho K. J Bone Miner Metab; 2022 Jul; 40(4):657-662. PubMed ID: 35534635 [Abstract] [Full Text] [Related]
2. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw. Baba A, Goto TK, Ojiri H, Takagiwa M, Hiraga C, Okamura M, Hasegawa S, Okuyama Y, Ogino N, Yamauchi H, Kobashi Y, Yamazoe S, Munetomo Y, Mogami T, Nomura T. Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278 [Abstract] [Full Text] [Related]
3. Effect of bisphosphonates on healing of tooth extraction wounds in infectious osteomyelitis of the jaw. Yamashita J, Sawa N, Sawa Y, Miyazono S. Bone; 2021 Feb; 143():115611. PubMed ID: 32829042 [Abstract] [Full Text] [Related]
9. Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in urological malignancies: a multi-center retrospective study. Sakai Y, Shindo T, Sato S, Takahashi A, Kunishima Y, Kato R, Itoh N, Okada M, Tachiki H, Taguchi K, Takayanagi A, Hotta H, Horita H, Matsukawa M, Matsuki M, Nishiyama K, Miyazaki A, Hashimoto K, Tanaka T, Masumori N. J Bone Miner Metab; 2021 Jul; 39(4):661-667. PubMed ID: 33704573 [Abstract] [Full Text] [Related]
10. Clinical risk factors for severity and prognosis of antiresorptive agent-related osteonecrosis of the jaw: a retrospective observational study. Nashi M, Hirai T, Iwamoto T, Takenobu T. J Bone Miner Metab; 2022 Nov; 40(6):1014-1020. PubMed ID: 36166107 [Abstract] [Full Text] [Related]
11. Relationships of opacification in the nasal sinuses, rhinosinusitis, and antiresorptive agent-related osteonecrosis of the jaw. Matsumoto Y, Yokoi H, Ikeda T, Kawada M, Saito K. Auris Nasus Larynx; 2020 Dec; 47(6):996-1002. PubMed ID: 32591168 [Abstract] [Full Text] [Related]
12. Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis. Voss PJ, Steybe D, Poxleitner P, Schmelzeisen R, Munzenmayer C, Fuellgraf H, Stricker A, Semper-Hogg W. Odontology; 2018 Oct; 106(4):469-480. PubMed ID: 29713913 [Abstract] [Full Text] [Related]
15. A Case of Osteomyelitis of the Mandibular Condyle Secondary to Bisphosphonate-related Osteonecrosis of the Jaw. Kato H, Uchibori M, Nakanishi Y, Kaneko A. Tokai J Exp Clin Med; 2020 Sep 20; 45(3):126-130. PubMed ID: 32901900 [Abstract] [Full Text] [Related]
17. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study. Ristow O, Rückschloß T, Müller M, Berger M, Kargus S, Pautke C, Engel M, Hoffmann J, Freudlsperger C. J Craniomaxillofac Surg; 2019 Mar 20; 47(3):491-499. PubMed ID: 30642734 [Abstract] [Full Text] [Related]
19. Synchronous antiresorptive osteonecrosis of the jaws and breast cancer metastasis. Flores IL, dos Santos-Silva AR, Della Coletta R, Vargas PA, Lopes MA. Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar 20; 117(3):e264-8. PubMed ID: 24528798 [Abstract] [Full Text] [Related]